Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression

Background: Natural speech analytics has seen some improvements over recent years, and this has opened a window for objective and quantitative diagnosis in psychiatry. Here, we used a machine learning algorithm applied to natural speech to ask whether language properties measured before psilocybin f...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2018
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01650327_v230_n_p84_Carrillo
http://hdl.handle.net/20.500.12110/paper_01650327_v230_n_p84_Carrillo
Aporte de:
id paper:paper_01650327_v230_n_p84_Carrillo
record_format dspace
spelling paper:paper_01650327_v230_n_p84_Carrillo2023-06-08T15:14:37Z Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression Computational psychiatry Depression Machine learning Natural speech analysis Predict therapeutic effectiveness Psilocybin treatment Treatment-resistant depression psilocybine antidepressant agent psilocybine psychedelic agent adult Article autobiographical memory Bayesian learning clinical article clinical outcome controlled clinical trial controlled study depression assessment female human male mental patient open study prediction priority journal psychopharmacotherapy psychosocial care quantitative analysis Quick Inventory of Depressive Symptoms 16 speech analysis treatment resistant depression treatment response algorithm case control study clinical trial episodic memory language machine learning middle aged physiology procedures speech speech analysis treatment resistant depression Adult Algorithms Antidepressive Agents Case-Control Studies Depressive Disorder, Treatment-Resistant Female Hallucinogens Humans Language Machine Learning Male Memory, Episodic Middle Aged Psilocybin Speech Speech Production Measurement Background: Natural speech analytics has seen some improvements over recent years, and this has opened a window for objective and quantitative diagnosis in psychiatry. Here, we used a machine learning algorithm applied to natural speech to ask whether language properties measured before psilocybin for treatment-resistant can predict for which patients it will be effective and for which it will not. Methods: A baseline autobiographical memory interview was conducted and transcribed. Patients with treatment-resistant depression received 2 doses of psilocybin, 10 mg and 25 mg, 7 days apart. Psychological support was provided before, during and after all dosing sessions. Quantitative speech measures were applied to the interview data from 17 patients and 18 untreated age-matched healthy control subjects. A machine learning algorithm was used to classify between controls and patients and predict treatment response. Results: Speech analytics and machine learning successfully differentiated depressed patients from healthy controls and identified treatment responders from non-responders with a significant level of 85% of accuracy (75% precision). Conclusions: Automatic natural language analysis was used to predict effective response to treatment with psilocybin, suggesting that these tools offer a highly cost-effective facility for screening individuals for treatment suitability and sensitivity. Limitations: The sample size was small and replication is required to strengthen inferences on these results. © 2018 2018 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01650327_v230_n_p84_Carrillo http://hdl.handle.net/20.500.12110/paper_01650327_v230_n_p84_Carrillo
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Computational psychiatry
Depression
Machine learning
Natural speech analysis
Predict therapeutic effectiveness
Psilocybin treatment
Treatment-resistant depression
psilocybine
antidepressant agent
psilocybine
psychedelic agent
adult
Article
autobiographical memory
Bayesian learning
clinical article
clinical outcome
controlled clinical trial
controlled study
depression assessment
female
human
male
mental patient
open study
prediction
priority journal
psychopharmacotherapy
psychosocial care
quantitative analysis
Quick Inventory of Depressive Symptoms 16
speech analysis
treatment resistant depression
treatment response
algorithm
case control study
clinical trial
episodic memory
language
machine learning
middle aged
physiology
procedures
speech
speech analysis
treatment resistant depression
Adult
Algorithms
Antidepressive Agents
Case-Control Studies
Depressive Disorder, Treatment-Resistant
Female
Hallucinogens
Humans
Language
Machine Learning
Male
Memory, Episodic
Middle Aged
Psilocybin
Speech
Speech Production Measurement
spellingShingle Computational psychiatry
Depression
Machine learning
Natural speech analysis
Predict therapeutic effectiveness
Psilocybin treatment
Treatment-resistant depression
psilocybine
antidepressant agent
psilocybine
psychedelic agent
adult
Article
autobiographical memory
Bayesian learning
clinical article
clinical outcome
controlled clinical trial
controlled study
depression assessment
female
human
male
mental patient
open study
prediction
priority journal
psychopharmacotherapy
psychosocial care
quantitative analysis
Quick Inventory of Depressive Symptoms 16
speech analysis
treatment resistant depression
treatment response
algorithm
case control study
clinical trial
episodic memory
language
machine learning
middle aged
physiology
procedures
speech
speech analysis
treatment resistant depression
Adult
Algorithms
Antidepressive Agents
Case-Control Studies
Depressive Disorder, Treatment-Resistant
Female
Hallucinogens
Humans
Language
Machine Learning
Male
Memory, Episodic
Middle Aged
Psilocybin
Speech
Speech Production Measurement
Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression
topic_facet Computational psychiatry
Depression
Machine learning
Natural speech analysis
Predict therapeutic effectiveness
Psilocybin treatment
Treatment-resistant depression
psilocybine
antidepressant agent
psilocybine
psychedelic agent
adult
Article
autobiographical memory
Bayesian learning
clinical article
clinical outcome
controlled clinical trial
controlled study
depression assessment
female
human
male
mental patient
open study
prediction
priority journal
psychopharmacotherapy
psychosocial care
quantitative analysis
Quick Inventory of Depressive Symptoms 16
speech analysis
treatment resistant depression
treatment response
algorithm
case control study
clinical trial
episodic memory
language
machine learning
middle aged
physiology
procedures
speech
speech analysis
treatment resistant depression
Adult
Algorithms
Antidepressive Agents
Case-Control Studies
Depressive Disorder, Treatment-Resistant
Female
Hallucinogens
Humans
Language
Machine Learning
Male
Memory, Episodic
Middle Aged
Psilocybin
Speech
Speech Production Measurement
description Background: Natural speech analytics has seen some improvements over recent years, and this has opened a window for objective and quantitative diagnosis in psychiatry. Here, we used a machine learning algorithm applied to natural speech to ask whether language properties measured before psilocybin for treatment-resistant can predict for which patients it will be effective and for which it will not. Methods: A baseline autobiographical memory interview was conducted and transcribed. Patients with treatment-resistant depression received 2 doses of psilocybin, 10 mg and 25 mg, 7 days apart. Psychological support was provided before, during and after all dosing sessions. Quantitative speech measures were applied to the interview data from 17 patients and 18 untreated age-matched healthy control subjects. A machine learning algorithm was used to classify between controls and patients and predict treatment response. Results: Speech analytics and machine learning successfully differentiated depressed patients from healthy controls and identified treatment responders from non-responders with a significant level of 85% of accuracy (75% precision). Conclusions: Automatic natural language analysis was used to predict effective response to treatment with psilocybin, suggesting that these tools offer a highly cost-effective facility for screening individuals for treatment suitability and sensitivity. Limitations: The sample size was small and replication is required to strengthen inferences on these results. © 2018
title Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression
title_short Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression
title_full Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression
title_fullStr Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression
title_full_unstemmed Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression
title_sort natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression
publishDate 2018
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01650327_v230_n_p84_Carrillo
http://hdl.handle.net/20.500.12110/paper_01650327_v230_n_p84_Carrillo
_version_ 1768545732926636032